We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOT icon
1001
Samsara
IOT
$21.2B
$6.7M 0.02%
539,122
+423,477
+366% +$4.82M
ETR icon
1002
Entergy
ETR
$52.9B
$6.66M 0.02%
+118,460
New +$6.49M
GOGN.WS
1003
CALL
DELISTED
GoGreen Investments Corporation Redeemable Warrants
GOGN.WS
$6.66M 0.02%
641,146
CDNS icon
1004
Cadence Design Systems
CDNS
$93.6B
$6.63M 0.01%
41,289
-273,604
-87% -$43.7M
KSS icon
1005
Kohl's
KSS
$2.09B
$6.61M 0.01%
261,766
+22,646
+9% +$642K
KSI
1006
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
$6.6M 0.01%
657,719
TLRY icon
1007
Tilray
TLRY
$499M
$6.59M 0.01%
+244,849
New +$8.58M
PATK icon
1008
Patrick Industries
PATK
$2.8B
$6.57M 0.01%
162,564
-53,349
-25% -$1.86M
EDR
1009
DELISTED
Endeavor Group Holdings, Inc.
EDR
$6.55M 0.01%
290,705
-487,638
-63% -$10.4M
HCSG icon
1010
Healthcare Services Group
HCSG
$1.57B
$6.55M 0.01%
545,627
-116,486
-18% -$1.54M
CRSR icon
1011
Corsair Gaming
CRSR
$1.09B
$6.52M 0.01%
480,328
+19,889
+4% +$289K
BKLN icon
1012
Invesco Senior Loan ETF
BKLN
$6.97B
$6.51M 0.01%
+316,923
New +$6.57M
MS icon
1013
CALL
Morgan Stanley
MS
$333B
$6.45M 0.01%
75,900
+19,900
+36% +$1.7M
ORCL icon
1014
CALL
Oracle
ORCL
$347B
$6.44M 0.01%
78,800
-92,500
-54% -$7.03M
NPWR icon
1015
NET Power
NPWR
$126M
$6.43M 0.01%
632,014
SLGC
1016
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$6.42M 0.01%
2,559,708
-436,818
-15% -$1.22M
CVS icon
1017
PUT
CVS Health
CVS
$137B
$6.42M 0.01%
68,900
+36,300
+111% +$3.5M
MATV icon
1018
Mativ Holdings
MATV
$453M
$6.41M 0.01%
306,920
-159,589
-34% -$3.46M
FXE icon
1019
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
$6.39M 0.01%
64,700
+34,000
+111% +$3.2M
IQMD
1020
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
$6.38M 0.01%
620,603
PRPC
1021
DELISTED
CC Neuberger Principal Holdings III
PRPC
$6.37M 0.01%
630,995
-1,032,316
-62% -$10.3M
SKGRW
1022
CALL
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$6.36M 0.01%
624,997
BRK.B icon
1023
Berkshire Hathaway Class B
BRK.B
$1.07T
$6.36M 0.01%
20,584
-72,114
-78% -$21.4M
MCAA
1024
DELISTED
Mountain & Co. I Acquisition Corp. Class A Ordinary Shares
MCAA
$6.32M 0.01%
609,189
MRT icon
1025
Marti Technologies
MRT
$162M
$6.32M 0.01%
619,936

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.